Lucintel Forecasts Renal Denervation Market to Reach $XX Billion by 2028

Category: Business

According to the recent study the renal denervation market is projected to reach an estimated $XX billion by 2028 from $XX billion in 2023, at a CAGR of 36% to 38% from 2023 to 2028. Growth in this market is primarily driven by rising frequency of hypertension, increasing elderly population and clinical advantages. Browse XX figures / charts and XX tables in this 150 -page report to understand trends, opportunities and forecast in renal denervation market by technology (micro infusion, pharmacologic ablation, radiofrequency ablation, and ultrasound ablation), product type (enligHTN RD system, symplicity RD system, vessix RD system, paradise RD system, iberis RD system, and others), disease type (hypertension, heart failure, diabetes, renal failure, and others), end use industry (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World). Download sample report by clicking on below link https://www.lucintel.com/renal-denervation-market.aspx “EnligHTN market is expected to remain the largest segment during the forecast period.” Based on product type, the renal denervation market is segmented into enligHTN RD system, symplicity RD system, vessix RD system, paradise RD system, iberis RD system, and others. Lucintel forecasts that the enligHTN market is expected to remain the largest segment due to the rising implementation of clinical studies to examine its efficacy in treating drug-resistant, uncontrolled hypertension. “Within the renal denervation market, the ultrasound ablation segment is expected to remain the largest technology” Based on technology the ultrasound ablation segment is expected to witness the highest growth over the forecast period due to its efficacy in trials and high effectiveness of catheter-based renal denervation procedures. “North America will dominate the renal denervation market in near future” North America will remain the largest region due to the increasing diagnosis and treatment rates, high adoption of advanced devices and growing number of research and development activities in the region. Download Brochure of this report by clicking on https://www.lucintel.com/renal-denervation-market.aspx Major players of renal denervation market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Medtronic, Boston Scientific, Kona Medical; Abbott, CardioSonic, Renal Dynamics, and Ablative Solutions are among the major renal denervation providers. This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/renal-denervation-market.aspx or helpdesk@lucintel.com